GLP-1s and other health conditions

PCOS, menopause, thyroid disease, fertility, interactions with common medications: where another diagnosis changes the conversation, and why screening matters.

7 articles · Who should not take a GLP-1 medication?

Who should not take a GLP-1 medication?

Contraindications, cautions, and why a clinician saying no is the system working — not a door slammed shut.

August 25, 2026 · 6 min read

GLP-1s and birth control: what the labels say

The tirzepatide labels advise extra contraceptive precautions around starting treatment and each dose increase. What that means in practice, and why.

October 2, 2026 · 6 min read

GLP-1s, pregnancy and breastfeeding

These medications are not for use in pregnancy. What the labels say about stopping before conceiving, why lead time matters, and what to do if you are pregnant.

October 2, 2026 · 6 min read

GLP-1s and PCOS: what is known

PCOS involves insulin resistance, which is why GLP-1s come up. What the approved indications cover, what they do not, and what to discuss.

October 2, 2026 · 6 min read

GLP-1s in perimenopause and menopause

Weight distribution changes, muscle is harder to keep and sleep is often disrupted. Why that context changes the GLP-1 conversation rather than the medication.

October 2, 2026 · 6 min read

GLP-1s and other medications: what to tell your clinician

Delayed stomach emptying affects how oral medications are absorbed, and some combinations raise hypoglycaemia risk. What the labels flag, and what to disclose.

October 2, 2026 · 6 min read

GLP-1s and thyroid conditions

The boxed warning concerns one specific thyroid cancer, not thyroid disease generally. What is contraindicated, what is not, and the levothyroxine question.

October 2, 2026 · 6 min read

Ready to see if you qualify?

It takes about two minutes — no cost, no obligation.

Get started